Regulation of differentiated properties and proliferation of arterial smooth muscle cells.
暂无分享,去创建一个
[1] D. Daret,et al. Prostacyclin production by cultured smooth muscle cells from atherosclerotic rabbit aorta , 1980, Nature.
[2] C. Dalsgaard,et al. Stimulation of connective tissue cell growth by substance P and substance K , 1985, Nature.
[3] G. Owens,et al. Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation , 1986, The Journal of cell biology.
[4] R. Wissler. The cellular pathobiology of atherosclerosis in 1983. , 1985, Advances in experimental medicine and biology.
[5] P. Wirth,et al. Regulation of alpha-smooth muscle actin and other polypeptides in proliferating and density-arrested vascular smooth muscle cells. , 1990, Journal of cellular physiology.
[6] C. Heldin,et al. Demonstration of stimulatory effects of platelet-derived growth factor on cultivated rat arterial smooth muscle cells. Differences between cells from young and adult animals. , 1983, Experimental cell research.
[7] M. Caton,et al. Prostaglandins and thromboxanes. , 1979, Progress in medicinal chemistry.
[8] Stephen M. Schwartz,et al. Developmentally regulated production of platelet-derived growth factor-like molecules , 1984, Nature.
[9] Richard O. Hynes,et al. Integrins: A family of cell surface receptors , 1987, Cell.
[10] Gary R. Grotendorst,et al. Platelet‐derived growth factor is a chemoattractant for vascular smooth muscle cells , 1982, Journal of cellular physiology.
[11] O. Kocher,et al. Cytodifferentiation and expression of alpha-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. , 1989, Arteriosclerosis.
[12] J. Klarlund. Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins , 1985, Cell.
[13] P. Needleman,et al. Arachidonic acid metabolism. , 1986, Annual review of biochemistry.
[14] S. Moncada. Prostacyclin and arterial wall biology. , 1982, Arteriosclerosis.
[15] R. Alexander,et al. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. , 1986, The Journal of biological chemistry.
[16] D. Cochran,et al. Effect of heparin on vascular smooth muscle cells. II. Specific protein synthesis , 1985, Journal of cellular physiology.
[17] D. Cochran,et al. Heparin modulates the secretion of a major excreted protein-like molecule by vascular smooth muscle cells. , 1988, Biochimica et biophysica acta.
[18] D. Payan. Receptor-mediated mitogenic effects of substance P on cultured smooth muscle cells. , 1985, Biochemical and biophysical research communications.
[19] R. Bryant,et al. Characterization of 11-HETE and 15-HETE, together with prostacyclin, as major products of the cyclooxygenase pathway in cultured rat aorta smooth muscle cells. , 1983, Journal of lipid research.
[20] C. Heldin,et al. Platelet-derived growth factor , 1985, Molecular and Cellular Endocrinology.
[21] A. Chobanian,et al. Growth factor expression in aorta of normotensive and hypertensive rats. , 1989, The Journal of clinical investigation.
[22] J. Chamley-Campbell,et al. What controls smooth muscle phenotype? , 1981, Atherosclerosis.
[23] A. Poole. Proteoglycans in health and disease: structures and functions. , 1986, The Biochemical journal.
[24] J. McDonald. Receptors for extracellular matrix components. , 1989, The American journal of physiology.
[25] J. Campbell,et al. Endothelial cell influences on vascular smooth muscle phenotype. , 1986, Annual review of physiology.
[26] R. Ross. The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.
[27] S. Schwartz,et al. Interactions of vascular wall cells with collagen gels. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[28] M. Moskowitz,et al. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[29] A. Griesmacher,et al. A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation. , 1988, The Biochemical journal.
[30] O. Kocher,et al. Expression of actin mRNAs in rat aortic smooth muscle cells during development, experimental intimal thickening, and culture. , 1986, Differentiation; research in biological diversity.
[31] G. Gabbiani,et al. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. , 1985, The Journal of clinical investigation.
[32] J. Mcgiff. Prostaglandins, prostacyclin, and thromboxanes. , 1981, Annual review of pharmacology and toxicology.
[33] R. Reddick,et al. Smooth Muscle Cell Proliferation in Response to Endothelial Injury in Coronary Arteries of Normal and von Willebrand's Disease Swine , 1984, Arteriosclerosis.
[34] A. Gown,et al. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.
[35] V. Koteliansky,et al. Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent , 1989, The Journal of cell biology.
[36] M. R. Murray,et al. A bibliography of the research in tissue culture 1884-1950 : an index to the literature of the living cell cultivated in vitro , 1953 .
[37] G. Cherqui,et al. Leukotriene D4-induced proliferation of glomerular epithelial cells: PKC- and Na+-H+ exchanger-mediated response. , 1989, The American journal of physiology.
[38] J. Chamley-Campbell,et al. INVITED REVIEW: THE CELLULAR PATHOBIOLOGY OF ATHEROSCLEROSIS , 1981, Pathology.
[39] S. Takebayashi,et al. Effects of collagen matrix on proliferation and differentiation of vascular smooth muscle cells in vitro. , 1990, Experimental and molecular pathology.
[40] S. Dower,et al. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. , 1989, Science.
[41] K. Yamada,et al. Cell surface receptors for extracellular matrix components. , 1990, Biochimica et biophysica acta.
[42] C. Stiles,et al. Regulation of cytoskeletal architecture by platelet-derived growth factor, insulin and epidermal growth factor. , 1984, Experimental cell research.
[43] B. Kommerell,et al. Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase. , 1985, The Journal of clinical investigation.
[44] T. Deuel,et al. Polypeptide growth factors: roles in normal and abnormal cell growth. , 1987, Annual review of cell biology.
[45] D. Daret,et al. Prostacyclin synthesis by proliferative aortic smooth muscle cells. A kinetic in vivo and in vitro study. , 1984, Atherosclerosis.
[46] P. Mosse,et al. Balloon Catheter Injury to Rabbit Carotid Artery: I. Changes in Smooth Muscle Phenotype , 1989, Arteriosclerosis.
[47] Wickremasinghe Rg. The role of prostaglandins in the regulation of cell proliferation. , 1988 .
[48] H. Weiss,et al. Human vascular smooth muscle cells in culture: growth characteristics and protein pattern by use of serum-free media supplements. , 1990, European journal of cell biology.
[49] R. Silverstein,et al. Thrombospondin: a versatile multifunctional glycoprotein. , 1986, Arteriosclerosis.
[50] M. Yanagisawa,et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[51] C. Heldin,et al. Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner , 1988, The Journal of cell biology.
[52] A. Vaheri,et al. Fibronectin and atherosclerosis. , 2009, Acta medica Scandinavica. Supplementum.
[53] J. Thyberg,et al. Effects of colchicine on DNA synthesis, endocytosis and fine structure of cultivated arterial smooth muscle cells. , 1983, Experimental cell research.
[54] E. Ruoslahti,et al. Extracellular matrices and cell adhesion. , 1985, Arteriosclerosis.
[55] E. Brown,et al. Angiotensin II rapidly increases phosphatidate-phosphoinositide synthesis and phosphoinositide hydrolysis and mobilizes intracellular calcium in cultured arterial muscle cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[56] E. Ruoslahti,et al. A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[57] Y. Hirata,et al. Endothelin is a potent mitogen for rat vascular smooth muscle cells. , 1989, Atherosclerosis.
[58] J. Vandekerckhove,et al. Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[59] M. Peach,et al. Angiotensin II Induces Hypertrophy, not Hyperplasia, of Cultured Rat Aortic Smooth Muscle Cells , 1988, Circulation research.
[60] M. Lagarde,et al. Metabolic interactions between eicosanoids in blood and vascular cells. , 1989, The Biochemical journal.
[61] J. Lawler. The structural and functional properties of thrombospondin. , 1986, Blood.
[62] R. Chalkley,et al. Characterization of actin mRNA levels during BC3H1 cell differentiation. , 1986, The Journal of biological chemistry.
[63] C. Heldin,et al. Structural and functional aspects of the receptors for platelet-derived growth factor. , 1989, Progress in growth factor research.
[64] J. Thyberg,et al. Phenotype modulation in primary cultures of smooth-muscle cells from rat aorta. Synthesis of collagen and elastin. , 1986, Differentiation; research in biological diversity.
[65] W. Moolenaar. Effects of growth factors on intracellular pH regulation. , 1986, Annual review of physiology.
[66] K. Yamada,et al. Vitronectin exists in two structurally and functionally distinct forms in human plasma. , 1989, Biochimica et biophysica acta.
[67] J. Vandekerckhove,et al. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. , 1984, The Journal of clinical investigation.
[68] W. Frazier. Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells , 1987, The Journal of cell biology.
[69] B. Caleb,et al. Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells [published erratum appears in J Cell Biol 1990 Mar;110(3):863] , 1989, The Journal of cell biology.
[70] Hans Michael Piper,et al. Cell Culture Techniques in Heart and Vessel Research , 1990, Springer Berlin Heidelberg.
[71] S. Singer,et al. Direct morphological demonstration of the coexistence of vimentin and desmin in the same intermediate filaments of vascular smooth muscle cells. , 1987, Journal of submicroscopic cytology.
[72] S. Kawamoto,et al. Characterization of myosin heavy chains in cultured aorta smooth muscle cells. A comparative study. , 1987, Journal of Biological Chemistry.
[73] M. Karnovsky,et al. Structural determinants of heparin's growth inhibitory activity. Interdependence of oligosaccharide size and charge. , 1989, The Journal of biological chemistry.
[74] S. Inoue. Ultrastructure of basement membranes. , 1989, International review of cytology.
[75] O. Kocher,et al. Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. , 1986, Human pathology.
[76] M. Moskowitz,et al. Serotonin receptor-mediated stimulation of bovine smooth muscle cell prostacyclin synthesis and its modulation by platelet-derived growth factor. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[77] H. Ditschuneit,et al. Interaction of receptors for insulin-like growth factor I, platelet-derived growth factor, and fibroblast growth factor in rat aortic cells. , 1987, Endocrinology.
[78] C. Bonne,et al. Differential effects of leukotrienes B4 and C4 on bovine aortic endothelial cell proliferation in vitro. , 1987, Prostaglandins.
[79] G. Owens,et al. Differential effect of platelet-derived growth factor- versus serum-induced growth on smooth muscle alpha-actin and nonmuscle beta-actin mRNA expression in cultured rat aortic smooth muscle cells. , 1989, The Journal of biological chemistry.
[80] V. Koteliansky,et al. Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries. , 1987, Atherosclerosis.
[81] P. Dartsch,et al. Growth characteristics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing and restenosing lesions. , 1990, Arteriosclerosis.
[82] H. Sarau,et al. The signal transduction system of the leukotriene D4 receptor. , 1989, Trends in pharmacological sciences.
[83] G. King,et al. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. , 1989, Molecular endocrinology.
[84] N. E. Owen. Effect of prostaglandin E1 on DNA synthesis in vascular smooth muscle cells. , 1986, The American journal of physiology.
[85] P. Ghezzi,et al. Platelet derived growth factor induces ornithine decarboxylase activity in NIH 3T3 cells. , 1985, Biochemical and Biophysical Research Communications - BBRC.
[86] G. Pinkus,et al. Immunohistochemical localization of smooth muscle myosin in normal human tissues. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[87] P. Rubenstein,et al. Induction of vascular smooth muscle alpha-isoactin expression in BC3H1 cells. , 1984, The Journal of biological chemistry.
[88] M. Yanagisawa,et al. A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. , 1989, The Journal of biological chemistry.
[89] H. Erickson,et al. Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion. , 1990, Journal of cell science.
[90] J. L. Alford,et al. Developmental changes in collagen and elastin biosynthesis in the porcine aorta. , 1986, Developmental biology.
[91] G. Owens,et al. Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells , 1988, The Journal of cell biology.
[92] T. Deuel,et al. Human platelet-derived growth factor. Purification and resolution into two active protein fractions. , 1981, The Journal of biological chemistry.
[93] J. Thyberg,et al. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells , 1988, The Journal of cell biology.
[94] M. Hosang. Suramin binds to platelet‐derived growth factor and inhibits its biological activity , 1985, Journal of cellular biochemistry.
[95] D. Gospodarowicz,et al. Basic fibroblast growth factor: expression in cultured bovine vascular smooth muscle cells. , 1988, European journal of cell biology.
[96] D. Cochran,et al. Effect of heparin on vascular smooth muscle cells. I. Cell metabolism , 1985, Journal of cellular physiology.
[97] J. G. Leslie,et al. Elastin structure, biosynthesis, and relation to disease states. , 1981, The New England journal of medicine.
[98] M. Karnovsky,et al. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. , 1982, The Journal of biological chemistry.
[99] S. Shears,et al. Metabolism of the inositol phosphates produced upon receptor activation. , 1989, The Biochemical journal.
[100] C. Dalsgaard,et al. Neuropeptides as growth factors. Possible roles in human diseases , 1989, Regulatory Peptides.
[101] M. Berridge. Inositol trisphosphate and diacylglycerol as second messengers. , 1984, The Biochemical journal.
[102] R F Doolittle,et al. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. , 1983, Science.
[103] G. Bondjers,et al. Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.
[104] D. Mosher. Physiology of thrombospondin. , 1990, Annual review of medicine.
[105] K. Weber,et al. Co-existence of vimentin and desmin type intermediate filaments in a subpopulation of adult rat vascular smooth muscle cells growing in primary culture. , 1982, Experimental cell research.
[106] W. Pallie. Embryology of the Human Arterial System (Arteriogenesis) , 1980 .
[107] M. Jokinen,et al. Animal models in atherosclerosis research. , 1985, Experimental and molecular pathology.
[108] F. Dieterlen‐Lièvre,et al. Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells. , 1987, Development.
[109] L. Matrisian,et al. Differential effects of lysosomotropic amines and polyamines on processing and biological activity of EGF. , 1984, Experimental cell research.
[110] L. Hokin,et al. Role of phosphoinositides in transmembrane signaling. , 1990, Physiological reviews.
[111] G. Sonenshein,et al. Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. , 1989, The Journal of biological chemistry.
[112] M. Denis,et al. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. , 1987, Journal of immunology.
[113] D. Hood,et al. Epidermal growth factor-mediated effects on equine vascular smooth muscle cells. , 1988, The American journal of physiology.
[114] P. Halushka,et al. Thromboxane, prostaglandin and leukotriene receptors. , 1989, Annual review of pharmacology and toxicology.
[115] H. Antoniades,et al. Platelet-derived growth factor binds specifically to receptors on vascular smooth muscle cells and the binding becomes nondissociable. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[116] R. Rappaport,et al. Establishment of the mechanism of cytokinesis in animal cells. , 1986, International review of cytology.
[117] T. Libermann,et al. Regulation of cell proliferation by epidermal growth factor. , 1983, CRC critical reviews in biochemistry.
[118] C. Heldin,et al. Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[119] J. Schlessinger. The epidermal growth factor receptor as a multifunctional allosteric protein. , 1988, Biochemistry.
[120] Y. Nishizuka,et al. Phosphatidylinositol turnover in receptor mechanism and signal transduction. , 1985, Annual review of pharmacology and toxicology.
[121] R. Ross,et al. Platelet-derived growth factor and its role in health and disease. , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[122] H. F. Epstein,et al. Muscle development--molecular and cellular control , 1982 .
[123] A. Gown,et al. Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. , 1986, Arteriosclerosis.
[124] R. Timpl,et al. Structure, development, and molecular pathology of basement membranes. , 1986, International review of experimental pathology.
[125] E. Edelman,et al. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[126] A. Ben-Ze'ev. Cell shape, the complex cellular networks, and gene expression. Cytoskeletal protein genes as a model system. , 1985, Cell and muscle motility.
[127] J. Thyberg,et al. Integrin-type fibronectin receptors of rat arterial smooth muscle cells: isolation, partial characterization and role in cytoskeletal organization and control of differentiated properties. , 1989, Differentiation; research in biological diversity.
[128] R. Alexander,et al. Vasoactive effects of growth factors. , 1989, Biochemical pharmacology.
[129] Gerrity Rg,et al. The aortic tunica media of the developing rat. I. Quantitative stereologic and biochemical analysis. , 1975 .
[130] G. Owens,et al. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. , 1989, The American journal of physiology.
[131] R. Majack. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures , 1987, The Journal of cell biology.
[132] C. Heldin,et al. Rat skeletal myoblasts and arterial smooth muscle cells express the gene for the A chain but not the gene for the B chain (c-sis) of platelet-derived growth factor (PDGF) and produce a PDGF-like protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[133] R. Gerrity,et al. The aortic tunica media of the developing rat. I. Quantitative stereologic and biochemical analysis. , 1975, Laboratory investigation; a journal of technical methods and pathology.
[134] B. Weksler,et al. Cholesterol metabolism is altered by hydrolytic metabolites of prostacyclin in arterial smooth muscle cells. , 1986, Journal of lipid research.
[135] W. Franke,et al. High frequency of cytokeratin-producing smooth muscle cells in human atherosclerotic plaques. , 1989, Differentiation; research in biological diversity.
[136] B. Fredholm,et al. Induction of ornithine decarboxylase activity and putrescine synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. , 1987, Experimental cell research.
[137] C. Heldin,et al. Platelet-derived growth factor: purification and partial characterization. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[138] B. Voss,et al. Localization of collagen types I, III, IV and V, fibronectin and laminin in human arteries by the indirect immunofluorescence method. , 1986, Pathology, research and practice.
[139] K. Mark,et al. Antagonistic effects of laminin and fibronectin on the expression of the myogenic phenotype , 1989 .
[140] G. Gabbiani,et al. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation , 1986, The Journal of cell biology.
[141] E. Weber,et al. Inducibleendothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells , 1990 .
[142] T. Barrett,et al. sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[143] A. Pegg,et al. The role of polyamines in somatomedin‐stimulated differentiation of L6 myoblasts , 1984, Journal of cellular physiology.
[144] G. Hansson,et al. Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro. , 1988, Experimental cell research.
[145] G. Owens,et al. Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells , 1988, The Journal of cell biology.
[146] T. McCaffrey,et al. Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity , 1988, The Journal of experimental medicine.
[147] Johannes A. G. Rhodin,et al. Architecture of the Vessel Wall , 1980 .
[148] J. Pouysségur. The growth factor-activatable Na+/H+ exchange system: a genetic approach , 1985 .
[149] B. Herman,et al. Platelet-derived growth factor-induced alterations in vinculin distribution in porcine vascular smooth muscle cells. , 1987, Cell motility and the cytoskeleton.
[150] V. Dzau,et al. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.
[151] R. Eddy,et al. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines , 1986, Nature.
[152] J. Thyberg,et al. Phenotype modulation in primary cultures of arterial smooth-muscle cells. Dual effect of prostaglandin E1. , 1984, Differentiation; research in biological diversity.
[153] H. Hämmerle,et al. Cytocontractile structures and proteins of smooth muscle cells during the formation of experimental lesions. , 1987, Experimental and molecular pathology.
[154] R. Ross,et al. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[155] R. Rosenberg,et al. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor , 1987, Journal of cellular physiology.
[156] J. Fleisch,et al. Leukotriene receptor antagonists as potential therapeutic agents. , 1989, Annual review of pharmacology and toxicology.
[157] R. Ross,et al. THE SMOOTH MUSCLE CELL I. In Vivo Synthesis of Connective Tissue Proteins , 1971 .
[158] W. Risau,et al. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. , 1988, Developmental biology.
[159] R. Timpl,et al. Role of laminin and fibronectin in selecting myogenic versus fibrogenic cells from skeletal muscle cells in vitro. , 1986, Developmental biology.
[160] G. Milo,et al. Polyunsaturated fatty acids, vitamin E, and the proliferation of aortic smooth muscle cells. , 1979, Lipids.
[161] H. Evans. On the development of the aortae, cardinal and umbilical veins, and the other blood vessels of vertebrate embryos from capillaries , 1909 .
[162] V. Tertov,et al. Content and localization of fibronectin in normal intima, atherosclerotic plaque, and underlying media of human aorta. , 1984, Atherosclerosis.
[163] W. Smith,et al. The eicosanoids and their biochemical mechanisms of action. , 1989, The Biochemical journal.
[164] R. Ross,et al. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. , 1984, The American journal of pathology.
[165] M. Clozel,et al. Specific binding of endothelin on human vascular smooth muscle cells in culture. , 1989, The Journal of clinical investigation.
[166] M. Kang,et al. Correlation between fibronectin and its receptor in chick myoblast differentiation , 1990, Journal of cellular physiology.
[167] B. Geiger,et al. Epidermal growth factor induces redistribution of actin and alpha-actinin in human epidermal carcinoma cells. , 1981, Experimental cell research.
[168] J. Boissel,et al. Growth‐stimulating effect of catecholamines on rat aortic smooth muscle cells in culture , 1983, Journal of cellular physiology.
[169] M. Hollenberg,et al. Epidermal growth factor stimulation of prostacyclin production by cultured aortic smooth muscle cells: Requirement for increased cellular calcium levels , 1989, Journal of cellular physiology.
[170] J. Thyberg,et al. Leukotrienes stimulate initiation of DNA synthesis in cultured arterial smooth muscle cells. , 1987, Journal of cell science.
[171] M. Bienkowski,et al. Regulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by platelet-derived growth factor. , 1989, The Journal of biological chemistry.
[172] B. Ransil,et al. Vascular smooth muscle cell kinetics: a new assay for studying patterns of cellular proliferation in vivo. , 1979, Science.
[173] Clowes Aw,et al. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[174] R. Gryglewski,et al. Prostaglandins, platelets, and atherosclerosis. , 1980, CRC critical reviews in biochemistry.
[175] R. Gerrity,et al. The aortic tunica media of the developing rat. II. Incorporation by medial cells 3-H-proline into collagen and elastin: autoradiographic and chemical studies. , 1975, Laboratory investigation; a journal of technical methods and pathology.
[176] R. Ross,et al. Purification of human platelet-derived growth factor. , 1985, Methods in enzymology.
[177] J. Thyberg,et al. Cell surface components and growth regulation in cultivated arterial smooth muscle cells. , 1983, Journal of cell science.
[178] P. Bornstein,et al. Heparin and related glycosaminoglycans modulate the secretory phenotype of vascular smooth muscle cells , 1984, The Journal of cell biology.
[179] C. Franzblau,et al. Elastin mRNA levels and insoluble elastin accumulation in neonatal rat smooth muscle cell cultures. , 1988, Biochemistry.
[180] L. Jonasson,et al. Smooth muscle cells express Ia antigens during arterial response to injury. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[181] J. Schlessinger,et al. Fibronectin delays the fusion of L6 myoblasts. , 1979, Experimental cell research.
[182] E. Rozengurt,et al. The role of cytoplasmic microtubules in the regulation of the activity of peptide growth factors. , 1980, Advances in enzyme regulation.
[183] J. Thyberg,et al. Phenotype modulation in primary cultures of arterial smooth-muscle cells: reorganization of the cytoskeleton and activation of synthetic activities. , 1985, Differentiation; research in biological diversity.
[184] Gary R. Grotendorst,et al. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[185] L. Cantley,et al. Mitogens and ion fluxes. , 1988, Annual review of physiology.
[186] R. Ross,et al. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[187] J. Thyberg,et al. Electron microscopic observations on the formation of elastic fibers in primary cultures of aortic smooth muscle cells. , 1977, Journal of ultrastructure research.
[188] Yanagisawa Masashi,et al. Endothelin, a novel endothelium-derived peptide: Pharmacological activities, regulation and possible roles in cardiovascular control , 1989 .
[189] C. Heldin,et al. Platelet-derived growth factor: three isoforms and two receptor types. , 1989, Trends in genetics : TIG.
[190] J. Smith,et al. Vanadium ions stimulate DNA synthesis in Swiss mouse 3T3 and 3T6 cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[191] R. Rutherford,et al. Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate , 1976, The Journal of cell biology.
[192] J. Herbert,et al. Heparin interactions with cultured human vascular endothelial and smooth muscle cells: Incidence on vascular smooth muscle cell proliferation , 1989, Journal of cellular physiology.
[193] J. Winkles,et al. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[194] H. Erickson,et al. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. , 1989, Annual review of cell biology.
[195] P. Vischer,et al. A possible role of catecholamines in atherogenesis and subsequent complications of atherosclerosis. , 1987, Experimental pathology.
[196] D. Carey,et al. Inhibition of proteoglycan synthesis alters extracellular matrix deposition, proliferation, and cytoskeletal organization of rat aortic smooth muscle cells in culture , 1989, The Journal of cell biology.
[197] Y. Yoshikawa,et al. Role of macrophages in atherosclerosis. Sequential observations of cholesterol-induced rabbit aortic lesion by the immunoperoxidase technique using monoclonal antimacrophage antibody. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[198] C. Heldin,et al. Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. , 1988, The EMBO journal.
[199] R. Ardaillou,et al. Leukotriene C4 binds to human glomerular epithelial cells and promotes their proliferation in vitro. , 1985, The Journal of clinical investigation.
[200] T. Maciag,et al. Hormonal requirements for growth of arterial smooth muscle cells in vitro: and endocrine approach to atherosclerosis. , 1981, Science.
[201] E. Ruoslahti,et al. Purification and characterization of vitronectin. , 1987, Methods in enzymology.
[202] H. Hämmerle,et al. Expression of smooth muscle myosin in relation to growth kinetics of cultured aortic smooth muscle cells. , 1988, Experimental cell research.
[203] D. Clemmons. Interaction of circulating cell‐derived and plasma growth factors in stimulating cultured smooth muscle cell replication , 1984, Journal of cellular physiology.
[204] R. Alexander,et al. Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. , 1985, The Journal of clinical investigation.
[205] A. Faerman,et al. A 90-kd surface antigen from a subpopulation of smooth muscle cells from human atherosclerotic lesions. , 1989, The American journal of pathology.
[206] C. Reilly. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin , 1990, Journal of cellular physiology.
[207] Julie H. Campbell,et al. Vascular smooth muscle in culture , 1987 .
[208] B. Weksler,et al. Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. , 1982, The Journal of clinical investigation.
[209] L. Chen,et al. Alteration in cell surface LETS protein during myogenesis , 1977, Cell.
[210] S. Yamamoto,et al. Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. , 1990, Molecular pharmacology.
[211] H. Kanaide,et al. Metabolism of glycosaminoglycans of cultured rat aortic smooth muscle cells altered during subculture. , 1983, British journal of experimental pathology.
[212] M. Sporn,et al. Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.
[213] M. Waterfield,et al. Platelet-derived growth factor elicits cyclic AMP accumulation in swiss 3T3 cells: Role of prostaglandin production , 1983, Cell.
[214] R. Alexander,et al. Vasoconstriction: a new activity for platelet-derived growth factor. , 1986, Science.
[215] B. Rollins,et al. Platelet-derived growth factor generates at least two distinct intracellular signals that modulate gene expression. , 1988, Cold Spring Harbor symposia on quantitative biology.
[216] M. Sporn,et al. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells , 1986, The Journal of cell biology.
[217] R. Mayne. Collagenous proteins of blood vessels. , 1986, Arteriosclerosis.
[218] Matthias Chiquet,et al. Tenascin interferes with fibronectin action , 1988, Cell.
[219] P. Majerus. Arachidonate metabolism in vascular disorders. , 1983, The Journal of clinical investigation.
[220] N. Tonks,et al. Protein tyrosine dephosphorylation and signal transduction. , 1989, Trends in biochemical sciences.
[221] P. Libby,et al. Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. , 1988, The New England journal of medicine.
[222] R. Alexander,et al. Myosin in cultured vascular smooth muscle cells: immunofluorescence and immunochemical studies of alterations in antigenic expression , 1984, The Journal of cell biology.
[223] R. Tucker. Role of microtubules and centrioles in growth regulation of mammalian cells. , 1983, Cell and muscle motility.
[224] S. Crooke,et al. Leukotriene D4 treatment of bovine aortic endothelial cells and murine smooth muscle cells in culture results in an increase in phospholipase A2 activity. , 1986, The Journal of biological chemistry.
[225] R. Ross,et al. Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens , 1981, The Journal of cell biology.
[226] J. Thyberg,et al. Changes in expression and organization of smooth-muscle-specific alpha-actin during fibronectin-mediated modulation of arterial smooth muscle cell phenotype. , 1990, Differentiation; research in biological diversity.
[227] C. Heldin,et al. Similar action of platelet‐derived growth factor and epidermal growth factor in the prereplicative phase of human fibroblasts suggests a common intracellular pathway , 1985, Journal of cellular physiology.
[228] Yanagisawa Masashi,et al. Molecular biology and biochemistry of the endothelins. , 1989 .
[229] O. Kocher,et al. Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. , 1984, Laboratory investigation; a journal of technical methods and pathology.
[230] A. Pegg. Recent advances in the biochemistry of polyamines in eukaryotes. , 1986, The Biochemical journal.
[231] R. Ross,et al. Platelet-derived growth factor. II. Specific binding to cultured cells. , 1982, Journal of Biological Chemistry.
[232] J. Rosenbloom. [9] Elastin: An overview , 1987 .
[233] S Grinstein,et al. Na+/H+ exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation. , 1989, Biochimica et biophysica acta.
[234] W. Mckeehan,et al. Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[235] A. Bobik,et al. Growth factor activity of endothelin on vascular smooth muscle. , 1990, The American journal of physiology.
[236] T. Maciag,et al. The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.
[237] V. Dixit,et al. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation , 1988, The Journal of cell biology.
[238] T. Resink,et al. Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. , 1989, Hypertension.
[239] B. Caleb,et al. Binding and internalization of heparin by vascular smooth muscle cells , 1985, Journal of cellular physiology.
[240] J. Thyberg,et al. Effects of leukotrienes on phenotypic properties and growth of arterial smooth muscle cells in primary culture. , 1989, Journal of cell science.
[241] C. Heldin,et al. Isoform‐specific induction of actin reorganization by platelet‐derived growth factor suggests that the functionally active receptor is a dimer. , 1989, The EMBO journal.
[242] P. Libby,et al. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. , 1986, The Journal of clinical investigation.
[243] T. Sejersen,et al. DNA synthesis induced by the neuropeptide substance K correlates to the level of myc-gene transcripts. , 1986, Biochemical and biophysical research communications.
[244] P. Bornstein,et al. Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[245] Julie H. Campbell,et al. Collagen synthesis by cultured rabbit aortic smooth-muscle cells. Alteration with phenotype. , 1990, The Biochemical journal.
[246] E. Scarpini,et al. Analysis of fibronectin expression during human muscle differentiation. , 1986, Basic and applied histochemistry.
[247] L. Heickendorff. The basement membrane of arterial smooth muscle cells. , 1989, APMIS. Supplementum.
[248] A. Daoud,et al. Association of DNA synthesis and apparent dedifferentiation of aortic smooth muscle cells in vitro. , 1970, Experimental and molecular pathology.
[249] G. FitzGerald,et al. Eicosanoid biosynthesis in human cardiovascular disease. , 1987, Human pathology.
[250] R. Ross,et al. Synthesis of connective tissue macromolecules by smooth muscle. , 1979, International review of connective tissue research.
[251] G. Gabbiani,et al. Correlation between the distribution of smooth muscle or non muscle myosins and alpha-smooth muscle actin in normal and pathological soft tissues. , 1988, Cell motility and the cytoskeleton.
[252] A. Olsson,et al. Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. , 1984, Atherosclerosis.
[253] J. Campbell,et al. Smooth muscle phenotypic expression in human carotid arteries. II. Atherosclerosis-free diffuse intimal thickenings compared with the media. , 1986, Arteriosclerosis.
[254] R. Rosenberg,et al. Heparin‐like molecules regulate the number of epidermal growth factor receptors on vascular smooth muscle cells , 1988, Journal of cellular physiology.
[255] D. Stumpo,et al. Effects of mitogens on ornithine decarboxylase activity and messenger RNA levels in normal and protein kinase C-deficient NIH-3T3 fibroblasts. , 1986, The Journal of biological chemistry.
[256] H. Waldmann,et al. Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies , 1985, The Journal of pathology.
[257] Y. Yoshida,et al. Increased production of prostacyclin (PGI2) by vascular intimal smooth muscle cells from atherosclerotic rabbit aorta. , 1988, Prostaglandins.
[258] H. Ehrlich,et al. Studies on vascular smooth muscle cells and dermal fibroblasts in collagen matrices. Effects of heparin. , 1986, Experimental cell research.
[259] R. Ross,et al. Platelet‐derived growth factor: Morphologic and biochemical studies of binding, internalization, and degradation , 1984, Journal of cellular physiology.
[260] G. Gabbiani,et al. Cytoskeletal remodeling of rat aortic smooth muscle cells in vitro: relationships to culture conditions and analogies to in vivo situations. , 1986, Journal of submicroscopic cytology.
[261] G. Carpenter,et al. EPIDERMAL GROWTH FACTOR * , 1982, The Journal of biological chemistry.
[262] G. Milo,et al. Fatty acids and their prostaglandin derivatives: inhibitors of proliferation in aortic smooth muscle cells. , 1977, Science.
[263] W. Pledger,et al. Platelet-derived growth factor-induced alterations in vinculin and actin distribution in BALB/c-3T3 cells , 1985, The Journal of cell biology.
[264] P. Rubenstein,et al. A vascular smooth muscle alpha-isoactin biosynthetic intermediate in BC3H1 cells. Identification of acetylcysteine at the NH2 terminus. , 1984, The Journal of biological chemistry.
[265] R. Ross,et al. The biology of platelet-derived growth factor , 1986, Cell.
[266] B. Samuelsson. Prostaglandins and Thromboxanes , 1977, NATO Advanced Study Institutes Series.
[267] R. Alexander,et al. Functional angiotensin II receptors in cultured vascular smooth muscle cells , 1982, The Journal of cell biology.
[268] B. Fredholm,et al. Adenosine receptor‐mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells , 1985, Journal of cellular physiology.
[269] N. Morisaki,et al. Lack of inhibition of DNA synthesis by prostaglandin I2 in cultured intimal smooth muscle cells from rabbits. , 1988, Atherosclerosis.
[270] A. Strauch,et al. Sequential expression of smooth muscle and sarcomeric alpha-actin isoforms during BC3H1 cell differentiation. , 1989, The Journal of biological chemistry.
[271] K. Resch,et al. Interleukin 1: more than a mediator between leukocytes. , 1988, Trends in pharmacological sciences.
[272] J. Rosenbloom. Elastin: an overview. , 1987, Methods in enzymology.
[273] B. Samuelsson. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.
[274] Julie H. Campbell,et al. Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[275] R. Coffey,et al. Transforming growth factor β regulation of cell proliferation , 1987, Journal of cellular physiology. Supplement.
[276] O. Kocher,et al. Cytoskeletal Features of Rat Aortic Cells during Development: An Electron Microscopic, Immunohistochemical, and Biochemical Study , 1985, Circulation research.
[277] J. Vandekerckhove,et al. Permanently proliferating rat vascular smooth muscle cell with maintained expression of smooth muscle characteristics, including actin of the vascular smooth muscle type , 1980, The Journal of cell biology.
[278] S. Coughlin,et al. Signal transduction by the platelet-derived growth factor receptor. , 1988, Cold Spring Harbor symposia on quantitative biology.
[279] Akira,et al. Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells , 1988, The Journal of cell biology.
[280] D. Donoghue,et al. Structure and function of platelet-derived growth factor (PDGF) and related proteins. , 1989, Biochimica et biophysica acta.
[281] D. Clemmons. Exposure to platelet-derived growth factor modulates the porcine aortic smooth muscle cell response to somatomedin-C. , 1985, Endocrinology.
[282] C. Nathan,et al. Secretory products of macrophages. , 1987, The Journal of clinical investigation.
[283] Cotran Rs,et al. The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation , 1989 .
[284] C. Dalsgaard,et al. Coupling between inositol phosphate formation and DNA synthesis in smooth muscle cells stimulated with neurokinin A , 1988, Journal of cellular physiology.
[285] J. Campbell,et al. Lipid accumulation in arterial smooth muscle cells. Influence of phenotype. , 1983, Atherosclerosis.
[286] G. Owens,et al. Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. , 1986, The Journal of biological chemistry.
[287] A. Gown,et al. A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes , 1985, The Journal of cell biology.
[288] J. Voorhees,et al. Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes , 1985, The British journal of dermatology.
[289] R. Rosenberg,et al. Heparin inhibition of smooth muscle cell proliferation: A cellular site of action , 1986, Journal of cellular physiology.
[290] R. Cotran,et al. The pathogenesis of atherosclerosis: atherogenesis and inflammation. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[291] M. Majesky,et al. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta , 1990, The Journal of cell biology.
[292] N. Morisaki,et al. Effects of smooth muscle cell derived growth factor (SDGF) in combination with other growth factors on smooth muscle cells. , 1989, Atherosclerosis.
[293] J. Campbell,et al. Glycosaminoglycan synthesis by smooth muscle cells of differing phenotype and their response to endothelial cell conditioned medium. , 1990, Atherosclerosis.
[294] T. Resink,et al. Decreased susceptibility of cultured smooth muscle cells from SHR rats to growth inhibition by heparin , 1989, Journal of cellular physiology.
[295] D. Gospodarowicz,et al. Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture , 1981, The Journal of cell biology.
[296] T. Hunter. A thousand and one protein kinases , 1987, Cell.
[297] T. Nikkari,et al. Characterization of the phenotype of smooth muscle cells in human fetal aorta on the basis of ultrastructure, immunofluorescence, and the composition of cytoskeletal and cytocontractile proteins. , 1988, Atherosclerosis.
[298] P. Woll,et al. A role for neuropeptides in the control of cell proliferation. , 1987, Developmental biology.
[299] J. Thyberg,et al. Attachment Substrates for Smooth Muscle Cells , 1990 .
[300] R. A. Murphy,et al. Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. , 1986, The Journal of biological chemistry.
[301] Y. Nishizuka. Studies and perspectives of protein kinase C. , 1986, Science.
[302] N. Giles. Induction of ornithine decarboxylase activity by insulin and growth factors is mediated by amino acids " , 2022 .
[303] P. Libby,et al. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. , 1988, The Journal of clinical investigation.
[304] E. Ruoslahti. Fibronectin and its receptors. , 1988, Annual review of biochemistry.
[305] M. Yanagisawa,et al. Endothelin receptor is coupled to phospholipase C via a pertussis toxin-insensitive guanine nucleotide-binding regulatory protein in vascular smooth muscle cells. , 1990, The Journal of clinical investigation.
[306] G. Gabbiani,et al. Distribution of vimentin and desmin filaments in smooth muscle tissue of mammalian and avian aorta. , 1982, Experimental cell research.
[307] G. Luk,et al. 8 – Polyamine Synthesis Inhibitors Act as both Inducers and Suppressors of Cell Differentiation , 1987 .
[308] T. Barrett,et al. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[309] T. Ishimitsu,et al. Regulatory effects of eicosanoids on thymidine uptake by vascular smooth muscle cells of rats. , 1988, Prostaglandins.
[310] R. Alexander,et al. Endothelin stimulates diacylglycerol accumulation and activates protein kinase C in cultured vascular smooth muscle cells. , 1989, The Journal of biological chemistry.
[311] P. Nestel,et al. Metabolism of Atherogenic Lipoproteins by Smooth Muscle Cells of Different Phenotype in Culture , 1985, Arteriosclerosis.
[312] R. Ross,et al. Low density lipoprotein receptor-dependent prostaglandin synthesis in Swiss 3T3 cells stimulated by platelet-derived growth factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[313] G. Carpenter,et al. Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells , 1989, Molecular and cellular biology.
[314] R. Timpl. Structure and biological activity of basement membrane proteins. , 1989, European journal of biochemistry.
[315] A. Otto. Microtubules and the regulation of DNA synthesis in fibroblastic cells. (A minireview). , 1982, Cell biology international reports.
[316] Paul Stroobant,et al. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus , 1983, Nature.
[317] D. Clemmons,et al. Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. , 1985, The Journal of clinical investigation.
[318] F. Watt. The extracellular matrix and cell shape , 1986 .
[319] C. Heldin,et al. Surface binding and internalization of platelet-derived growth factor in human fibroblasts. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[320] S. Schwartz,et al. Replication of smooth muscle cells in vascular disease. , 1986, Circulation research.
[321] M. Bernfield,et al. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet‐derived growth factor , 1986, Journal of Cellular Physiology.
[322] K. Kariya,et al. Stimulation of phospholipase C-mediated hydrolysis of phosphoinositides by endothelin in cultured rabbit aortic smooth muscle cells. , 1989, Biochemical and biophysical research communications.
[323] D. Smith,et al. Eicosanoid effects on cell proliferation in vitro: relevance to atherosclerosis. , 1984, Prostaglandins, leukotrienes, and medicine.
[324] R. Chiquet‐Ehrismann,et al. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.
[325] R. Timpl,et al. Synthesis of type IV collagen and laminin in cultures of skeletal muscle cells and their assembly on the surface of myotubes. , 1982, Developmental biology.
[326] C. Heldin,et al. Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[327] M. Lark,et al. Modulation of proteoglycan metabolism by aortic smooth muscle cells grown on collagen gels. , 1986, Arteriosclerosis.
[328] L. Jonasson,et al. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. , 1986, Clinical and experimental immunology.
[329] M. Reidy,et al. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[330] G. Carpenter,et al. Epidermal growth factor, its receptor, and related proteins. , 1986, Experimental cell research.
[331] R. Rosenberg,et al. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells , 1985, The Journal of cell biology.
[332] A. Horwitz,et al. Cell surface receptors for extracellular matrix molecules. , 1987, Annual review of cell biology.
[333] R. Alexander,et al. Heterogeneity of myosin antigenic expression in vascular smooth muscle in vivo. , 1984, Laboratory investigation; a journal of technical methods and pathology.
[334] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[335] L. Cantley,et al. Phosphoinositide metabolism and the control of cell proliferation. , 1989, Biochimica et biophysica acta.
[336] O. Kocher,et al. Arterial smooth muscle cells in vivo: relationship between actin isoform expression and mitogenesis and their modulation by heparin , 1988, The Journal of cell biology.
[337] R. Zaragoza,et al. Heparin inhibits Na(+)-H+ exchange in vascular smooth muscle cells. , 1990, The American journal of physiology.
[338] G. Campbell,et al. Balloon Catheter Injury to Rabbit Carotid Artery: II. Selective Increase in Reactivity to Some Vasoconstrictor Drugs , 1989, Arteriosclerosis.
[339] H. Nakamura,et al. Electron microscopic study of the prenatal development of the thoracic aorta in the rat. , 1988, The American journal of anatomy.
[340] R. Ross,et al. Platelet-derived Growth Factor , 2022 .
[341] B. Westermark,et al. A platelet factor stimulating human normal glial cells. , 1976, Experimental cell research.
[342] B. Westermark,et al. Influence of epidermal growth factor (EGF) on ruffling activity, pinocytosis and proliferation of cultivated human glia cells. , 1976, Experimental cell research.
[343] N. Morisaki,et al. Secretion of a new growth factor, smooth muscle cell derived growth factor, distinct from platelet derived growth factor by cultured rabbit aortic smooth muscle cells , 1988, FEBS letters.
[344] T. Nikkari,et al. Prostaglandins enhance the synthesis of glycosaminoglycans and inhibit the growth of rabbit aortic smooth muscle cells in culture. , 1980, Artery.
[345] P. Bonin,et al. Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte derived growth factor. , 1989, Experimental cell research.
[346] B. Kommerell,et al. Evidence for coordinate, selective regulation of eicosanoid synthesis in platelet-derived growth factor-stimulated 3T3 fibroblasts and in HL-60 cells induced to differentiate into macrophages or neutrophils. , 1988, The Journal of biological chemistry.
[347] K. Lau,et al. Phosphotyrosyl protein phosphatases. , 1989, The Biochemical journal.
[348] V. Dixit,et al. Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. , 1987, The Journal of biological chemistry.
[349] A. J. Valente,et al. Cultured primate aortic smooth muscle cells express both the PDGF‐‐A and PDGF‐B genes but do not secrete mitogenic activity or dimeric platelet‐derived growth factor protein , 1988, Journal of cellular physiology.
[350] A. Clowes,et al. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[351] N. Joyce,et al. Interaction of angiotensin II with functional smooth muscle cells in culture. , 1987, The American journal of physiology.
[352] P. Libby,et al. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. , 1990, The Journal of clinical investigation.
[353] E. Edelman,et al. Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. , 1989, Arteriosclerosis.
[354] A. Clowes,et al. Suppression by heparin of smooth muscle cell proliferation in injured arteries , 1977, Nature.
[355] M. Moskowitz,et al. Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor , 1980, Nature.
[356] M. Barnes,et al. Collagens in atherosclerosis. , 1985, Collagen and related research.
[357] M. Yanagisawa,et al. Molecular biology and biochemistry of the endothelins. , 1989, Trends in pharmacological sciences.
[358] I. Herman. Extracellular matrix-cytoskeletal interactions in vascular cells. , 1987, Tissue & cell.
[359] J. Thyberg,et al. A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. , 1989, Developmental biology.
[360] A. A. Spector,et al. Hydroxyeicosatetraenoic acids (HETEs). , 1988, Progress in lipid research.
[361] P. Bornstein,et al. Heparin regulates the collagen phenotype of vascular smooth muscle cells: induced synthesis of an Mr 60,000 collagen , 1985, The Journal of cell biology.
[362] C. Littlewood,et al. Endothelin stimulates DNA synthesis in Swiss 3T3 cells. Synergy with polypeptide growth factors. , 1989, The Biochemical journal.
[363] A. Ullrich,et al. Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.
[364] B. Oakes,et al. The synthesis of elastin, collagen, and glycosaminoglycans by high density primary cultures of neonatal rat aortic smooth muscle. An ultrastructural and biochemical study. , 1982, European journal of cell biology.
[365] L. Ehrhart,et al. Substratum influence on collagen and fibronectin biosynthesis by arterial smooth muscle cells in vitro , 1986, Journal of cellular physiology.
[366] R. van Wijk,et al. Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E1. , 1985, Experimental cell research.
[367] H. Ziegler-Heitbrock. The biology of the monocyte system. , 1989, European journal of cell biology.
[368] S. Schwartz,et al. Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[369] A. Pardee. G1 events and regulation of cell proliferation. , 1989, Science.
[370] Y. Yazaki,et al. Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cells , 1988, FEBS letters.
[371] R. Majack,et al. Vascular smooth muscle cells express distinct transforming growth factor-beta receptor phenotypes as a function of cell density in culture. , 1989, The Journal of biological chemistry.
[372] P. Libby,et al. Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells , 1987, The Journal of experimental medicine.
[373] Kathleen M. Smith,et al. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.
[374] P. Bornstein,et al. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells , 1985, The Journal of cell biology.
[375] N. Morisaki,et al. Cell cycle-dependent inhibition of DNA synthesis by prostaglandin I2 in cultured rabbit aortic smooth muscle cells. , 1988, Atherosclerosis.
[376] J. Thyberg,et al. The microtubular cytoskeleton and the initiation of DNA synthesis. , 1984, Experimental cell research.
[377] C. Ashall,et al. Fibronectin distribution in human aortic intima and atherosclerotic lesions: concentration of soluble and collagenase-releasable fractions. , 1986, Biochimica et biophysica acta.
[378] M. Bissell,et al. The Influence of Extracellular Matrix on Gene Expression: Is Structure the Message? , 1987, Journal of Cell Science.
[379] A. Lipton,et al. Platelets as a source of fibroblast growth-promoting activity. , 1974, Experimental cell research.
[380] B. Berk,et al. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. , 1989, Hypertension.
[381] R. Alexander,et al. Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. , 1989, The Journal of biological chemistry.
[382] A. Desmoulière,et al. Detection of atherosclerotic plaque with two monoclonal antibodies. 2P1A2 monoclonal antibody is specific for smooth muscle cells in atherosclerotic plaque. , 1988, Atherosclerosis.
[383] S. Dahlén,et al. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.
[384] I. Herman,et al. Regulation of Vascular Smooth Muscle Cell Growth by Endothelial‐Synthesized Extracellular Matrices , 1987, Arteriosclerosis.
[385] C. Heldin,et al. Induction of circular membrane ruffling on human fibroblasts by platelet-derived growth factor. , 1988, Experimental cell research.
[386] D. Beeler,et al. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells , 1984, Journal of cellular physiology.
[387] B. Zetter,et al. Migration of cultured vascular cells in response to plasma and platelet-derived factors. , 1982, Journal of cell science.
[388] R. Ross,et al. Physiological quiescence in plasma‐derived serum: Influence of platelet‐derived growth factor on cell growth in culture , 1978, Journal of cellular physiology.
[389] B. Fredholm,et al. Modulation of arterial smooth muscle cells from contractile to synthetic phenotype requires induction of ornithine decarboxylase activity and polyamine synthesis. , 1987, Experimental cell research.
[390] J. Thyberg,et al. Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. , 1983, Differentiation; research in biological diversity.
[391] M. Daemen,et al. Alpha 1-adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta. , 1990, The Journal of biological chemistry.
[392] G. Wendelschafer‐Crabb,et al. Immunocytochemical localization of fibronectin (LETS protein) on the surface of L6 myoblasts: light and electron microscopic studies , 1978, Cell.
[393] J. Thyberg,et al. Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to synthetic phenotype. , 1987, Differentiation; research in biological diversity.
[394] T. Wight,et al. Cell biology of arterial proteoglycans. , 1989, Arteriosclerosis.
[395] W. Shier. Serum stimulation of phospholipase A2 and prostaglandin release in 3T3 cells is associated with platelet-derived growth-promoting activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[396] R. Wickremasinghe. The role of prostaglandins in the regulation of cell proliferation. , 1988, Prostaglandins, leukotrienes, and essential fatty acids.
[397] R. Rosenberg,et al. Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth , 1981, The Journal of cell biology.
[398] M. Zerial,et al. Identification of growth-factor-inducible genes in mouse fibroblasts. , 1988, Cold Spring Harbor symposia on quantitative biology.
[399] G. Gabbiani,et al. Vimentin-containing smooth muscle cells in aortic intimal thickening after endothelial injury. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[400] W. Smith. Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells. , 1986, Annual review of physiology.
[401] O. Kocher,et al. Analysis of alpha-smooth-muscle actin mRNA expression in rat aortic smooth-muscle cells using a specific cDNA probe. , 1987, Differentiation; research in biological diversity.
[402] T. Ogihara,et al. Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. , 1990, Biochemistry international.
[403] L. Kaczmarek. Protooncogene expression during the cell cycle. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[404] M. Hosang,et al. Human Vascular Smooth Muscle Cells Have at Least Two Distinct PDGF Receptors and Can Secrete PDGF‐AA , 1989, Journal of cardiovascular pharmacology.
[405] D. Belin,et al. Actin isoform synthesis and mRNA levels in quiescent and proliferating rat aortic smooth muscle cells in vivo and in vitro. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[406] P. Majerus,et al. The metabolism of phosphoinositide-derived messenger molecules. , 1986, Science.
[407] J. Vilček,et al. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[408] D. Hajjar,et al. Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism. , 1989, Arteriosclerosis.
[409] R. Ross,et al. Two classes of PDGF receptor recognize different isoforms of PDGF. , 1988, Science.
[410] E. Weber,et al. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. , 1990, Biochemical and biophysical research communications.
[411] A. Clowes,et al. Kinetics of Cellular Proliferation after Arterial Injury: IV. Heparin Inhibits Rat Smooth Muscle Mitogenesis and Migration , 1986, Circulation research.
[412] R. Ross,et al. The smooth muscle cell in culture. , 1979, Physiological reviews.